date,title,source
Oct-22-18,Why Aduro Biotech Crashed 29.5% Today,Motley Fool
Oct-23-18,Aduro Biotech (ADRO) Q3 Earnings Preview: What's in the Cards?,Zacks
Oct-26-18,Aduro Presents Preclinical Data for Anti-APRIL Antibody BION-1301 for the Treatment of IgA Nephropathy at ASN Kidney Week 2018,GlobeNewswire
Oct-30-18,"Aduro Biotech (ADRO) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Oct-30-18,Aduro Biotech Reports Third Quarter 2018 Financial Results,GlobeNewswire
Oct-31-18,"Aduro (ADRO) Q3 Loss Narrower Than Expected, Revenues Lag",Zacks
Nov-06-18,Aduro to Host and Webcast an Investor Event to Review Data Presented at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting,GlobeNewswire
Nov-09-18,Aduro Biotech Presents Preliminary Results from Ongoing Phase 1 Trials of STING agonist ADU-S100 (MIW815) in Patients with Advanced Solid Tumors or Lymphomas,GlobeNewswire
Dec-03-18,Aduro Biotech and Dana-Farber Cancer Institute Present Preclinical Data Supporting Anti-APRIL Antibody BION-1301 for the Treatment of Multiple Myeloma at the 60th American Society of Hematology Annual Meeting and Exposition,GlobeNewswire
Dec-12-18,Aduro Biotech Data Published in Cell Reports Highlights the Significant Role of the Magnitude of Intratumoral STING Activation by ADU-S100 in Anti-Tumor Immunity,GlobeNewswire
Dec-18-18,Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies,PR Newswire
Dec-19-18,These 4 Pharma Stocks Are Heating Up,ACCESSWIRE
Dec-19-18,Aduro Stock Surges on STING Activator Deal With Eli Lilly,Zacks
Dec-19-18,"Biotech Stock Roundup: Pipeline Updates From VRTX & AMGN, ADRO Teams Up With LLY",Zacks
Dec-19-18,Today's Research Reports on Trending Tickers: Nektar Therapeutics and Aduro BioTech,ACCESSWIRE
Dec-20-18,"What You Must Know About Aduro BioTech, Inc.s (NASDAQ:ADRO) Financial Strength",Simply Wall St.
Dec-20-18,"The Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and Incyte",Zacks
Dec-20-18,Today's Research Reports on Trending Tickers: Aduro BioTech and Adial Pharmaceuticals,ACCESSWIRE
Dec-24-18,"Health Care Digest: 'Killing off' the JPM Week golden goose, a $75 million complement and more",American City Business Journals
Jan-03-19,Aduro Biotech to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-22-19,Vertex's Orkambi Wins EU Nod to Treat Cystic Fibrosis in Kids,Zacks
Jan-24-19,Athersys' (ATHX) MultiStem Cell Therapy Succeeds in Study,Zacks
Jan-24-19,Vertex Terminates COO Ian Smith on Code of Conduct Violation,Zacks
Jan-24-19,Amicus (FOLD) Boasts Strong Pipeline Amid Stiff Competition,Zacks
Jan-25-19,"Is Aduro BioTech, Inc. (NASDAQ:ADRO) A Volatile Stock?",Simply Wall St.
Jan-30-19,Aduro Biotech Announces Strategic Reset,GlobeNewswire
Feb-06-19,Top Ranked Momentum Stocks to Buy for February 6th,Zacks
Feb-07-19,Will Aduro Biotech Continue to Surge Higher?,Zacks
Feb-08-19,"AMAG Q4 Loss Narrower Than Expected, Revenues Lag Estimates",Zacks
Feb-11-19,Zoetis (ZTS) to Report Q4 Earnings: What's in the Cards?,Zacks
Feb-11-19,Merrimack (MACK) Stock Up Year to Date: Is a Rebound Likely?,Zacks
Feb-11-19,Aduro Announces First Patient Dosed in Phase 1 Study of ADU-S100 (MIW815) in Combination with YERVOY (ipilimumab) for the Treatment of Relapsed and Refractory Melanoma,GlobeNewswire
Feb-12-19,Aduro Initiates Dosing in Phase I Melanoma Study on ADU-S100,Zacks
Feb-13-19,5 Tiny Biotech Stocks With Superb Growth Potential,Zacks
Feb-14-19,"The Zacks Analyst Blog Highlights: BioDelivery, Cytokinetics, Celldex, Aduro and Aeterna",Zacks
Feb-14-19,"Consolidated Research: 2019 Summary Expectations for The Trade Desk, Aduro Biotech, Walker & Dunlop, California Resources, Century Casinos, and Arsanis  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Feb-14-19,Will Aduro Biotech Continue to Surge Higher?,Zacks
Feb-19-19,What's in Store for Sangamo (SGMO) This Earnings Season?,Zacks
Feb-20-19,Will Hospice Strength Show on Amedisys' (AMED) Q4 Earnings?,Zacks
Feb-20-19,What's in Store for Tandem Diabetes' (TNDM) Q4 Earnings?,Zacks
Feb-21-19,Will Difficult Comparison Hurt Bio-Rad's (BIO) Q4 Earnings?,Zacks
Feb-21-19,Aduro Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference,GlobeNewswire
Feb-21-19,Aduro Announces Changes to its Board of Directors,GlobeNewswire
Feb-22-19,What's in Store for Vericel (VCEL) This Earnings Season?,Zacks
Feb-25-19,Will Aduro Biotech Continue to Surge Higher?,Zacks
Feb-25-19,What's in Store for Universal Health (UHS) Q4 Earnings?,Zacks
Feb-25-19,Top Ranked Momentum Stocks to Buy for February 25th,Zacks
Feb-27-19,Aduro Biotech Reports Fourth Quarter and Full Year 2018 Financial Results,GlobeNewswire
Feb-27-19,Top Ranked Momentum Stocks to Buy for February 27th,Zacks
Feb-28-19,Aduro (ADRO) Q4 Earnings and Revenues Fall Shy of Estimates,Zacks
Feb-28-19,Top Ranked Momentum Stocks to Buy for February 28th,Zacks
Feb-28-19,Aduro Biotech Announces Upcoming Presentations at AACR Annual Meeting 2019,GlobeNewswire
Mar-01-19,The Meet Group (MEET) to Report Q4 Earnings: What's in Store?,Zacks
Mar-01-19,"What Should We Expect From Aduro BioTech, Inc.s (NASDAQ:ADRO) Earnings In The Years Ahead?",Simply Wall St.
Mar-07-19,Aduro Biotech to Present at Two Upcoming Investor Conferences in March,GlobeNewswire
Mar-27-19,Lilly (LLY) Signs New Immunology Deal With Private Biotech,Zacks
Apr-01-19,Aduro Biotech to Present at the H.C. Wainwright Global Life Sciences Conference,GlobeNewswire
Apr-08-19,"What Kind Of Shareholders Own Aduro BioTech, Inc. (NASDAQ:ADRO)?",Simply Wall St.
Apr-17-19,Aduro Biotech Abstracts Accepted for Presentation at the 2019 American Society of Clinical Oncology Annual Meeting,GlobeNewswire
Apr-18-19,"Aduro Biotech Appoints Experienced Financial Executive, Frank Karbe, to its Board of Directors",GlobeNewswire
Apr-22-19,Exact Sciences (EXAS) to Post Q1 Earnings: What's in Store?,Zacks
Apr-22-19,Is a Beat in Store for AbbVie (ABBV) This Earnings Season?,Zacks
Apr-22-19,"Aduro Biotech Appoints Dimitry S.A. Nuyten, M.D., Ph.D. as Chief Medical Officer",GlobeNewswire
Apr-24-19,What's in Store for Vertex (VRTX) This Earnings Season?,Zacks
Apr-24-19,What's in the Cards for Amarin (AMRN) This Earnings Season?,Zacks
Apr-24-19,Trevena (TRVN) to Post Q1 Earnings: What Awaits the Stock?,Zacks
Apr-24-19,"Anthem's (ANTM) Q1 Earnings Beat Estimates, Improve Y/Y",Zacks
Apr-24-19,Aduro Biotech (ADRO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?,Zacks
Apr-24-19,5 Biotech Stocks Defying the Medicare-for-All Scare,Zacks
Apr-25-19,Tenet Healthcare (THC) to Post Q1 Earnings: What's in Store?,Zacks
Apr-25-19,Is a Beat in Store for Editas (EDIT) This Earnings Season?,Zacks
Apr-25-19,"The Zacks Analyst Blog Highlights: Incyte, Aduro Biotech, MeiraGTx and Coherus BioSciences",Zacks
Apr-26-19,"Universal Health (UHS) Q1 Earnings, Revenues Miss Estimates",Zacks
Apr-26-19,What's in Store for HCA Healthcare's (HCA) Q1 Earnings?,Zacks
Apr-26-19,Is a Beat in Store for WellCare Health's (WCG) Q1 Earnings?,Zacks
